WallStreetZenWallStreetZen

NASDAQ: ETNB
89bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for ETNB

Based on 4 analysts offering 12 month price targets for 89bio Inc.
Min Forecast
$14.00+52.84%
Avg Forecast
$27.75+202.95%
Max Forecast
$37.00+303.93%

Should I buy or sell ETNB stock?

Based on 4 analysts offering ratings for 89bio Inc.
Buy
Strong Buy
1 analysts 25%
Buy
2 analysts 50%
Hold
1 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ETNB stock forecasts and price targets.

ETNB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-05
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2024-03-07
lockedlocked$00.00+00.00%2024-03-01

1 of 1

Forecast return on equity

Is ETNB forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is ETNB forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ETNB revenue forecast

What is ETNB's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$30.7M
Avg 2 year Forecast
$199.4M
Avg 3 year Forecast
$602.1M

ETNB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ETNB$9.16$27.75+202.95%Buy
SLN$21.56$57.25+165.54%Strong Buy
IMTX$10.23N/AN/A
SPRY$9.06$18.50+104.19%Buy
KYTX$20.43$39.50+93.34%Strong Buy

89bio Stock Forecast FAQ

Is 89bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: ETNB) stock is to Buy ETNB stock.

Out of 4 analysts, 1 (25%) are recommending ETNB as a Strong Buy, 2 (50%) are recommending ETNB as a Buy, 1 (25%) are recommending ETNB as a Hold, 0 (0%) are recommending ETNB as a Sell, and 0 (0%) are recommending ETNB as a Strong Sell.

If you're new to stock investing, here's how to buy 89bio stock.

What is ETNB's revenue growth forecast for 2026-2028?

(NASDAQ: ETNB) 89bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.

89bio's revenue in 2024 is $0.On average, 4 Wall Street analysts forecast ETNB's revenue for 2026 to be $2,872,637,675, with the lowest ETNB revenue forecast at $707,804,160, and the highest ETNB revenue forecast at $4,470,479,853. On average, 3 Wall Street analysts forecast ETNB's revenue for 2027 to be $18,641,336,238, with the lowest ETNB revenue forecast at $5,880,291,097, and the highest ETNB revenue forecast at $37,335,033,153.

In 2028, ETNB is forecast to generate $56,297,639,548 in revenue, with the lowest revenue forecast at $18,314,082,003 and the highest revenue forecast at $95,380,584,321.

What is ETNB's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ETNB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ETNB's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ETNB price target, the average ETNB price target is $27.75, with the highest ETNB stock price forecast at $37.00 and the lowest ETNB stock price forecast at $14.00.

On average, Wall Street analysts predict that 89bio's share price could reach $27.75 by Apr 5, 2025. The average 89bio stock price prediction forecasts a potential upside of 202.95% from the current ETNB share price of $9.16.

What is ETNB's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ETNB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.